-
On Friday, the Food and Drug Administration authorized emergency use of remdesivir for patients with severe cases of COVID-19. Drugmaker Gilead Sciences' lobbying hit a new high in the first quarter.
-
President Trump often talks about "draining the swamp" of inside dealers in Washington.But lobbyist Jeff Miller might be considered part of the new swamp.…